Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Instrument Maximizes Colony Isolation and Eliminates Cross-Contamination

By LabMedica International staff writers
Posted on 28 Apr 2010
A fully automated system processes up to 300 microbiology plates per hour, standardizing routine agar plate inoculation and offering fast turnaround times with improved traceability. More...


Dubbed Previ Isola, the instrument maximizes colony isolation and eliminates cross-contamination, streamlining laboratory workflows to save time and free staff for other tasks. The system features streaking technology, which maximizes colony isolation through pressure-controlled contact with the agar surface during inoculation, and uses the same quantity of inoculate every time to standardize results.

The automated specimen and agar plate-management system offer clinical laboratories flexibility for routine processing of samples. It is particularly suited to high-throughput applications where negative results are prevalent, such as MRSA or urine specimen screening.

A 2010 Medical Design Excellence Award (MDEA) was presented to BioMérieux for the Previ Isola, highlighting the automated media streaker's breakthrough technology, which has revolutionized front-end media processing tasks. The award was based on the Previ Isola's design and engineering features including new use of materials, improvements to healthcare delivery, and the ability of the product development team to overcome design and engineering challenges to better meet clinical objectives.

Related Links:
BioMérieux



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.